The DOI matches its Crossref record; 361 of the 361 references it cites were found in a registry or an index.
The age of anxiety: role of animal models of anxiolytic action in drug discovery
Open accessAbstract
Anxiety disorders are common, serious and a growing health problem worldwide. However, the causative factors, aetiology and underlying mechanisms of anxiety disorders, as for most psychiatric disorders, remain relatively poorly understood. Animal models are an important aid in giving insight into the aetiology, neurobiology and, ultimately, the therapy of human anxiety disorders. The approach, however, is challenged with a number of complexities. In particular, the heterogeneous nature of anxiety disorders in humans coupled with the associated multifaceted and descriptive diagnostic criteria, creates challenges in both animal modelling and in clinical research. In this paper, we describe some of the more widely used approaches for assessing the anxiolytic activity of known and potential therapeutic agents. These include ethological, conflict‐based, hyponeophagia, vocalization‐based, physiological and cognitive‐based paradigms. Developments in the characterization of translational models are also summarized, as are the challenges facing researchers in their drug discovery efforts in developing new anxiolytic drugs, not least the ever‐shifting clinical conceptualization of anxiety disorders. In conclusion, to date, although animal models of anxiety have relatively good validity, anxiolytic drugs with novel mechanisms have been slow to emerge. It is clear that a better alignment of the interactions between basic and clinical scientists is needed if this is to change. LINKED ARTICLES This article is part of a themed issue on Translational Neuropharmacology. To view the other articles in this issue visit http://dx.doi.org/10.1111/bph.2011.164.issue‐4
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–361 of 361
Sluyter, F., Korte, S. M., Bohus, B., & van Oortmerssen, G. A. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)02164-7 · Cited by 115
The modified hole board as a differential screen for behavior in rodents
Ohl, F., Holsboer, F., & Landgraf, R. (2001) · Behavior Research Methods, Instruments, & Computers · doi:10.3758/bf03195393 · Cited by 113
Effects of Mild Early Life Stress on Abnormal Emotion-related Behaviors in 5-HTT Knockout Mice
Carroll, J. C., Boyce‐Rustay, J. M., Millstein, R. A., Yang, R. J., Wiedholz, L. M., Murphy, D. L., & Holmes, A. (2006) · Behavior Genetics · doi:10.1007/s10519-006-9129-9 · Cited by 113
Ballard, T. M., Woolley, M. L., Prinssen, E. P. M., Huwyler, J., Porter, R., & Spooren, W. P. J. M. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2211-9 · Cited by 110
Sillaber, I., Panhuysen, M., Henniger, M. S. H., Ohl, F., Kühne, C., Pütz, B., Pohl, T., Deussing, J. M., Páez-Pereda, M., & Holsboer, F. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1232-6 · Cited by 109
Evaluation of Psychotropic Drugs with a Modified Open Field Test
Cunha, J. M., & Masur, J. (2008) · Pharmacology · doi:10.1159/000136777 · Cited by 109
Bouwknecht, J. A., & Paylor, R. E. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32830c3658 · Cited by 108
Pharmacological Evaluation of a Modified Open-Field Test Sensitive to Anxiolytic Drugs
Rex, A., Voigt, J., Voits, M., & Fink, H. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00461-9 · Cited by 108
Homanics, G. E., Harrison, N. L., Quinlan, J. J., Krasowski, M. D., Rick, C., Blas, A. L. D., Mehta, A. K., Kist, F., Mihalek, R., Aul, J. J., et al. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(98)00177-4 · Cited by 106
Holmes, A., Iles, J. P., Mayell, S. J., & Rodgers, R. J. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00184-x · Cited by 106
Heinrichs, S. C., Min, H., Tamraz, S., Carmouché, M., Boehme, S. A., & Vale, W. (1997) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(97)00030-9 · Cited by 106
Singewald, N. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.02.003 · Cited by 106
Shorter, E., & Tyrer, P. (2003) · BMJ · doi:10.1136/bmj.327.7407.158 · Cited by 105
McAuley, J. D., Stewart, A. L., Webber, E. S., Cromwell, H. C., Servatius, R. J., & Pang, K. C. H. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.05.036 · Cited by 104
Metabotropic glutamate receptor 7: At the interface of cognition and emotion
O’Connor, R. M., Finger, B. C., Flor, P. J., & Cryan, J. F. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.02.059 · Cited by 103
Self-citationKolber, B. J., Boyle, M. P., Wieczorek, L., Kelley, C. L., Onwuzurike, C., Nettles, S. A., Vogt, S. K., & Muglia, L. J. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.4470-09.2010 · Cited by 103
Schmitt, U., & Hiemke, C. (1998) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(98)00051-7 · Cited by 103
Shekhar, A., Keim, S. R., Simon, J. R., & McBride, W. J. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00077-9 · Cited by 101
Stefański, R., lejko, W. P. X., Kostowski, W., & Pałźnik, A. (1992) · Neuropharmacology · doi:10.1016/0028-3908(92)90053-r · Cited by 99
Influence of Contextual Fear on Sleep in Mice: A Strain Comparison
Sanford, L. D., Yang, L., & Tang, X. (2003) · SLEEP · doi:10.1093/sleep/26.5.527 · Cited by 99
Glutamate receptor ligands as anxiolytics.
Chojnacka-Wójcik, E., Kłodzińska, A., & Pilc, A. (2001) · PubMed · Cited by 99
The discriminative stimulus effects of pentylenetetrazol as a model of anxiety: recent developments
Jung, M. E., Lal, H., & Gatch, M. B. (2002) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(02)00010-6 · Cited by 97
Non-Peptidic CRF1 Receptor Antagonists for the Treatment of Anxiety, Depression and Stress Disorders
Kehne, B. S. P. J., & Lombaert, B. S. P. S. D. (2002) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007023339049 · Cited by 92
Acute pharmacological modulation of mGluR8 reduces measures of anxiety
Duvoisin, R. M., Pfankuch, T., Wilson, J. M., Grabell, J., Chhajlani, V., Brown, D. G., Johnson, E., & Raber, J. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.04.006 · Cited by 91
Conn, P. J., & Roth, B. L. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301638 · Cited by 90
Fear extinction in rodents: basic insight to clinical promise
Barad, M. (2005) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2005.10.005 · Cited by 90
Finger, B. C., Dinan, T. G., & Cryan, J. F. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1858-z · Cited by 90
Self-citationAnimal Models of Anxiety and Anxiolytic Drug Action
Treit, D., Engin, E., & McEown, K. (2009) · Current topics in behavioral neurosciences · doi:10.1007/7854_2009_17 · Cited by 89
Yilmazer‐Hanke, D., Faber‐Zuschratter, H., Linke, R., & Schwegler, H. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.01945.x · Cited by 88
A Comparative Review of Rodent Prefrontal Cortex and Working Memory
Jones, M. W. (2002) · Current Molecular Medicine · doi:10.2174/1566524023361989 · Cited by 87
Wu, L., Ko, S. W., Toyoda, H., Zhao, M., Xu, H., Vadakkan, K. I., Ren, M., Knifed, E., Shum, F. W. F., Quan, J., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000167 · Cited by 87
Avoidance, escape, and extinction as functions of shock intensity.
Boren, J. J., Sidman, M., & Herrnstein, R. J. (1959) · Journal of Comparative and Physiological Psychology · doi:10.1037/h0042727 · Cited by 87
mGlu5 receptor antagonists: A novel class of anxiolytics?
Spooren, W. P. J. M., & Gasparini, F. (2004) · Drug News & Perspectives · doi:10.1358/dnp.2004.17.4.829052 · Cited by 86
Shimazaki, T., Yoshimizu, T., & Chaki, S. (2006) · CNS Drugs · doi:10.2165/00023210-200620100-00002 · Cited by 85
Zhao, L., Kim, K. W., Ikeda, Y., Anderson, K. K., Beck, L., Chase, S., Tobet, S. A., & Parker, K. L. (2008) · Molecular Endocrinology · doi:10.1210/me.2008-0034 · Cited by 84
Jacobson, L. H., Bettler, B., Kaupmann, K., & Cryan, J. F. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0631-9 · Cited by 82
Self-citationGoldberg, M. E., Manian, A. A., & Efron, D. H. (1967) · Life Sciences · doi:10.1016/0024-3205(67)90051-3 · Cited by 82
Farrell, W., & Alberts, J. R. (2002) · Journal of comparative psychology · doi:10.1037/0735-7036.116.3.297 · Cited by 82
Generalised Anxiety Disorder: Treatment Options
Sramek, J. J., Zarotsky, V., & Cutler, N. R. (2002) · Drugs · doi:10.2165/00003495-200262110-00005 · Cited by 80
Anxiolytic-Like Effects of Antidepressants After Acute Administration in a Four-Plate Test in Mice
Hascoët, M., Bourin, M., Colombel, M. C., Fiocco, A. J., & Baker, G. B. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(99)00191-4 · Cited by 80
Animal Models of Obsessive‐Compulsive Disorder
Witkin, J. M. (2008) · Current Protocols in Neuroscience · doi:10.1002/0471142301.ns0930s45 · Cited by 79
A model of ???antipredator??? defense in Swiss-Webster mice
Griebel, G., Blanchard, D. C., Jung, Á. H., & Blanchard, R. J. (1995) · Behavioural Pharmacology · doi:10.1097/00008877-199511000-00009 · Cited by 79
Neural Pathways Underlying Lactate-Induced Panic
Johnson, P. L., Truitt, W. A., Fitz, S. D., Lowry, C. A., & Shekhar, A. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301621 · Cited by 78
Stachowicz, K., Brański, P., Kłak, K., van der Putten, H., Cryan, J. F., Flor, P. J., & Pilc, A. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32830cd839 · Cited by 78
Self-citationChandra, D., Korpi, E. R., Miralles, C. P., Blas, A. L. D., & Homanics, G. E. (2005) · BMC Neuroscience · doi:10.1186/1471-2202-6-30 · Cited by 78
Sleep after differing amounts of conditioned fear training in BALB/cJ mice
Sanford, L. D., Fang, J., & Tang, X. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(03)00180-3 · Cited by 75
The Maudsley Reactive and Nonreactive Strains: A New Perspective
Blizard, D. A., & Adams, N. (2002) · Behavior Genetics · doi:10.1023/a:1020206120248 · Cited by 74
Chlordiazepoxide modified exploration in rats
Hughes, R. N. (1972) · Psychopharmacology · doi:10.1007/bf00423436 · Cited by 73
Camp, M., Norcross, M. A., Whittle, N., Feyder, M. J., D’Hanis, W., Yilmazer‐Hanke, D., Singewald, N., & Holmes, A. (2009) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2009.00519.x · Cited by 72
Deficits in acquisition and extinction of conditioned responses in mGluR7 knockout mice
Goddyn, H., Callaerts‐Vegh, Z., Stroobants, S., Dirikx, T., Vansteenwegen, D., Hermans, D., van der Putten, H., & D’Hooge, R. (2008) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2008.01.001 · Cited by 72
Line, S. J., Barkus, C., Coyle, C., Jennings, K. A., Deacon, R. M. J., Lesch, K., Sharp, T., & Bannerman, D. M. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.08.005 · Cited by 72
Cholecystokinin and panic disorder: Past and future clinical research strategies
Bradwejn, J., & Koszycki, D. (2001) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/713783681 · Cited by 71
Pharmacology of human experimental anxiety
Graeff, F. G., Parente, A., Del-Ben, C. M., & Guimarães, F. S. (2003) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2003000400003 · Cited by 70 · cited 1×
“These include generating classical conditioned fear in humans, generating anxiety via public speaking, measuring attentiveness to threatening cues using the Stroop-word colour task, as well as measuring fear-potentiated startle in humans (Graeff et al., 2003).”
MethodTemporary disruption of fear-potentiated startle following PKMζ inhibition in the amygdala
Parsons, R. G., & Davis, M. (2011) · Nature Neuroscience · doi:10.1038/nn.2745 · Cited by 69
Cholecystokinin and panic disorder: Past and future clinical research strategies
Bradwejn, D. K. J., & Koszycki, D. (2001) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/clb.61.234.19.27 · Cited by 69
Pharmacology of methaminodiazepoxide.
Randall, L. O. (1960) · PubMed · Cited by 69
Hasegawa, S., Furuichi, T., Yoshida, T., Endoh, K., Kato, K., Sado, M., Maeda, R., Kitamoto, A., Miyao, T., Suzuki, R., et al. (2009) · Molecular Brain · doi:10.1186/1756-6606-2-6 · Cited by 68
Prolactin Levels and Maternal Behavior Induced by Ultrasonic Vocalizations of the Rat Pup.
Hashimoto, H., Saito, T. R., FURUDATE, S.-I., & TAKAHASHI, K. W. (2001) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.50.307 · Cited by 67
Wierońska, J. M., Stachowicz, K., Pałucha-Poniewiera, A., Acher, F., Brański, P., & Pilc, A. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.08.008 · Cited by 66
Molecular Signals into the Insular Cortex and Amygdala During Aversive Gustatory Memory Formation
Bermúdez‐Rattoni, F., Ramı́rez-Lugo, L., Gutiérrez, R., & Miranda, M. I. (2004) · Cellular and Molecular Neurobiology · doi:10.1023/b:cemn.0000012722.45805.c8 · Cited by 66
Santarelli, L., Gobbi, G., Blier, P., & Hen, R. (2002) · PubMed · Cited by 65
Use of the elevated T-maze to study anxiety in mice
de Carvalho-Netto, E. F., & Nunes‐de‐Souza, R. L. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(03)00184-0 · Cited by 65
Atack, J. R., Wafford, K. A., Street, L. O. N. D. O. N. G., Dawson, G. R., Tye, S. J., Laere, K. V., Bormans, G. M., Bohorquez, S. M. S., Lepeleire, I. D., de Hoon, J., et al. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109354927 · Cited by 65
Mombereau, C., Lhuillier, L., Kaupmann, K., & Cryan, J. F. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.116228 · Cited by 64
Self-citationAnxiogenic Effect of Cholecystokinin in the Dorsal Periaqueductal Gray
Netto, C. F., & Guimarães, F. S. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300334 · Cited by 64
Dekeyne, A., Brocco, M., Adhumeau-Auclair, A., Gobert, A., & Millan, M. J. (2000) · Psychopharmacology · doi:10.1007/s002130000449 · Cited by 62
Pharmacological enhancement of fear reduction: preclinical models
Graham, B. M., Langton, J. M., & Richardson, R. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01175.x · Cited by 62
Altered conditioned fear behavior in glutamate decarboxylase 65 null mutant mice
Stork, O., Yamanaka, H., Stork, S., Kume, N., & Obata, K. (2003) · Genes Brain & Behavior · doi:10.1034/j.1601-183x.2003.00008.x · Cited by 61
High social anxiety and low aggression in Fawn-Hooded rats
Kantor, S., Anheuer, Z. E., & Bagdy, G. (2000) · Physiology & Behavior · doi:10.1016/s0031-9384(00)00374-7 · Cited by 61
Nastiti, K., Benton, D., & Pf, B. (1991) · PubMed · Cited by 61
Aprison, M. H., & Ferster, C. B. (1961) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1961.tb13486.x · Cited by 60
Reliability of high and low anxiety-related behaviour:
Salomé, N., Viltart, O., Darnaudéry, M., Salchner, P., Singewald, N., Landgraf, R., Sequeira, H., & Wigger, A. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00135-3 · Cited by 58
Dierssen, M., Gratacòs, M., Sahún, I., Martín, M., Gallego, X., Amador‐Arjona, A., de Lagrán, M. M., Murtra, P., Martí, E., Pujana, M. Á., et al. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.07.015 · Cited by 58
Gatch, M. B. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00422-3 · Cited by 58
Thoeringer, C. K., Erhardt, A., Sillaber, I., Mueller, M., Ohl, F., Holsboer, F., & Keck, M. E. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109103091 · Cited by 58
Conditioned defensive burying as a model for identifying anxiolytics
Craft, R. M., Howard, J. L., & Pollard, G. T. (1988) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(88)90098-6 · Cited by 57
Jacobson, L. H., Kelly, P. H., Bettler, B., Kaupmann, K., & Cryan, J. F. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.2076-06.2006 · Cited by 57
Self-citationGriebel, G., Rodgers, R. J., Perrault, G., & Sanger, D. J. (1999) · Psychopharmacology · doi:10.1007/s002130050984 · Cited by 57
López-Aumatell, R., Blázquez, G., Gil, L., Aguilar, R., Cañete, T., Giménez‐Llort, L., Tobeña, A., & Fernández‐Teruel, A. (2009) · PubMed · Cited by 57
Kellner, M. B., Muhtz, C., Stark, K., Yassouridis, A., Arlt, J., & Wiedemann, K. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2025-1 · Cited by 56
Anxiety and cognition in female histidine decarboxylase knockout (Hdc−/−) mice
Acevedo, S. F., Pfankuch, T., Ohtsu, H., & Raber, J. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.10.016 · Cited by 56
Freezing reaction in panic disorder patients associated with anticipatory anxiety.
Lopes, F. L., Azevedo, T. M., Imbiriba, L. A., Freire, R. C., Valença, A. M., Caldirola, D., Perna, G., Volchan, E., & Nardi, A. E. (2009) · Depression and Anxiety · doi:10.1002/da.20593 · Cited by 54
Proposed Revisions to Psychiatry's Canon Unveiled
Miller, G. S., & Holden, C. (2010) · Science · doi:10.1126/science.327.5967.770-a · Cited by 53
Brain angiotensin and anxiety-related behavior: The transgenic rat TGR(ASrAOGEN)680
Voigt, J., Hörtnagl, H., Rex, A., van Hove, L., Bäder, M., & Fink, H. (2005) · Brain Research · doi:10.1016/j.brainres.2005.03.048 · Cited by 53
Zanoveli, J. M., Netto, C. F., Guimarães, F. S., & Zangrossi, H. (2004) · Peptides · doi:10.1016/j.peptides.2004.06.016 · Cited by 52
Ehninger, D., & Silva, A. J. (2010) · Behavior Genetics · doi:10.1007/s10519-010-9398-1 · Cited by 51
Vendruscolo, L. F., Takahashi, R. N., Brüske, G. R., & Ramos, A. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1545-4 · Cited by 50
Pharmacological Treatment of Generalized Anxiety Disorder
Baldwin, D. S., Ajel, K. I., & Garner, M. J. (2009) · Current topics in behavioral neurosciences · doi:10.1007/7854_2009_2 · Cited by 48
Sherif, F. M., & Oreland, L. (1995) · Behavioural Brain Research · doi:10.1016/0166-4328(96)00047-2 · Cited by 48
Buspirone and related compounds as alternative anxiolytics
Taylor, D. P., & Moon, S. L. (1991) · Neuropeptides · doi:10.1016/0143-4179(91)90078-w · Cited by 48
Dynamic processing of taste aversion extinction in the brain
Mickley, G. A., Kenmuir, C. L., McMullen, C. A., Yocom, A. M., Valentine, E. L., Crish, S. D., Weber, B., Wellman, J. A., & Remmers-Roeber, D. R. (2004) · Brain Research · doi:10.1016/j.brainres.2004.04.071 · Cited by 48
Kühn, R., Pagano, A., Stoehr, N., Vranesic, I., Flor, P. J., Lingenhöhl, K., Spooren, W. P. J. M., Gentsch, C., Vassout, A., Pilc, A., et al. (2002) · Amino Acids · doi:10.1007/s00726-001-0130-6 · Cited by 47
Kalueff, A. V., Keisala, T., Minasyan, A., Kumar, S. R., LaPorte, J. L., Murphy, D. L., & Tuohimaa, P. (2008) · Nature Protocols · doi:10.1038/nprot.2007.516 · Cited by 47
Barros, M., Maior, R. S., Huston, J. P., & Tomaz, C. A. B. (2008) · Reviews in the Neurosciences · doi:10.1515/revneuro.2008.19.2-3.157 · Cited by 46
Eser, D., Schüle, C., Baghai, T. C., Floesser, A., Krebs‐Brown, A., Enunwa, M., de la Motte, S., Engel, R. R., Kucher, K., & Rupprecht, R. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0738-7 · Cited by 45
Wacker, D. A., & Miller, K. J. (2008) · PubMed · Cited by 44
Kobayashi, S., Ohta, M., Miyasaka, K., & Funakoshi, A. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12881-0 · Cited by 44 · cited 2×
“…rat OLETF rat constitutively lacks the CCK1 receptor High levels of anxiety behaviour in the elevated plus maze, light–dark box and open field tests (Kobayashi et al., 1996; Yamamoto et al., 2000) mGluR5 receptor knock-out Mice with a targeted deletion of the mGlu5 receptor gene Increased anxiety…”
BackgroundEffects of four antipsychotics on punished responding in rats
Wiley, J. L., Compton, A. D., & Porter, J. H. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90237-n · Cited by 44
Role of apolipoprotein E in anxiety
Raber, J. (2007) · Neural Plasticity · doi:10.1155/2007/91236 · Cited by 44
Caffeine and 35% carbon dioxide challenge tests in panic disorder
Nardi, A. E., Valença, A. M., Lopes, F. L., Neto, V. L. D. M., Freire, R. C. R., Veras, A. B., Nascimento, I., King, A. L. S., Soares‐Filho, G. L., Mezzasalma, M. A., et al. (2007) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.840 · Cited by 43
GABA homeostasis contributes to the developmental programming of anxiety-related behavior
Depino, A. M., Tsetsenis, T., & Gross, C. T. (2008) · Brain Research · doi:10.1016/j.brainres.2008.03.006 · Cited by 42
Salomons, A. R., van Luijk, J. A. K. R., Reinders, N. R., Kirchhoff, S., Arndt, S. S., & Ohl, F. (2009) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2009.00527.x · Cited by 42
Genetic Approaches to Modeling Anxiety in Animals
Jacobson, L. H., & Cryan, J. F. (2009) · Current topics in behavioral neurosciences · doi:10.1007/7854_2009_31 · Cited by 41
Self-citationNardi, A. E., Valença, A. M., Mezzasalma, M. A., Lopes, F. L., Nascimento, I., Veras, A. B., Freire, R. C. R., Neto, V. L. D. M., & Zin, W. A. (2006) · Depression and Anxiety · doi:10.1002/da.20165 · Cited by 40
Nutt, D., Kessler, R. C., Alonso, J., Benbow, A., Lecrubier, Y., Lépine, J., Mechanic, D., & Tylee, A. T. (2007) · PubMed · Cited by 39
A schematic representation of the psychopharmacological profile of antidepressants
Bourin, M., Redrobe, J. P., Hascoët, M., Baker, G. B., & Colombel, M.-C. (1996) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(96)00134-0 · Cited by 38
Angelis, L. D., & Furlan, C. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(99)00237-3 · Cited by 38
The four-plates test: Anxiolytic or analgesic paradigm?
Ripoll, N., Hascoët, M., & Bourin, M. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.11.036 · Cited by 37
Anxiety-like state associates with taste to produce conditioned taste aversion
Guitton, M. J., & Dudai, Y. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.08.024 · Cited by 37
Increased anxiety behavior in OLETF rats without cholecystokinin-A receptor
Yamamoto, Y., Akiyoshi, J., Kiyota, A., Katsuragi, S., Tsutsumi, T., Isogawa, K., & Nagayama, H. (2000) · Brain Research Bulletin · doi:10.1016/s0361-9230(00)00407-x · Cited by 35
Hascoët, M., Bourin, M., & Dhonnchadha, B. Á. N. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00293-8 · Cited by 35
Conley, R. K., & Hutson, P. H. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.02.063 · Cited by 35
The Suok (“ropewalking”) murine test of anxiety
Kalueff, A. V., & Tuohimaa, P. (2005) · Brain Research Protocols · doi:10.1016/j.brainresprot.2004.11.002 · Cited by 35
Kronenberg, G., Berger, P., Tauber, R., Bandelow, B., Henkel, V., & Heuser, I. (2005) · Pharmacopsychiatry · doi:10.1055/s-2005-837768 · Cited by 34
Czech, D. A., & Quock, R. M. (1993) · Psychopharmacology · doi:10.1007/bf02245699 · Cited by 32
Anxiety-like and depression-like behavior in Maudsley reactive (MR) and non-reactive (NMRA) rats
Commissaris, R. L., Verbanac, J. S., Markovska, V. L., Altman, H. J., & Hill, T. J. (1996) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(96)00012-7 · Cited by 32
Low versus Standard Dose mCPP Challenge in Obsessive-Compulsive Patients
Erzegovesi, S. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00178-0 · Cited by 32
Brocco, M., Dekeyne, A., la Cour, C. M., Touzard, M., Girardon, S., Veiga, S., Nanteuil, G. D., A, T. R. D. J., Olivier, B., & Millan, M. J. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.06.002 · Cited by 31
van Bogaert, M. J. V., Oosting, R. S., Tóth, M., Groenink, L., van Oorschot, R., & Olivier, B. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.08.058 · Cited by 31
Plasma MHPG levels in lactate and isoproterenol anxiety states
Pohl, R., Ettedgui, E., Bridges, M., Lycaki, H., Jimerson, D. C., Kopin, I. J., & Rainey, J. M. (1987) · Biological Psychiatry · doi:10.1016/0006-3223(87)90054-0 · Cited by 30
Gomez‐Mancilla, B., Marrer, E., Kehren, J., Kinnunen, A., Imbert, G., Hillebrand, R., Bergström, M., & Schmidt, M. E. (2005) · NeuroRx · doi:10.1602/neurorx.2.4.683 · Cited by 30
Mongeau, R., & Marsden, C. A. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00407-6 · Cited by 29
The video-recorded stroop color-word test as a new model of experimentally-induced anxiety
Leite, J., Seabra, M. D. L. V., Sartori, V. A., & Andreatini, R. (1999) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(99)00042-1 · Cited by 29
E. Murphy, S. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791293051 · Cited by 26
Rodgers, R. J. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-045396-5.00002-6 · Cited by 26
Effects of midazolam on the expression of conditioned taste aversion in rats
Yasoshima, Y., & Yamamoto, T. (2005) · Brain Research · doi:10.1016/j.brainres.2005.02.070 · Cited by 26
Lactate- and isoproterenol-induced panic attacks in panic disorder patients and controls
Balon, R., Pohl, R. B., Yeragani, V. K., Rainey, J. M., & Weinberg, P. (1988) · Psychiatry Research · doi:10.1016/0165-1781(88)90005-4 · Cited by 25
The effects of 5-HT receptor ligands on ultrasonic calling in mouse pups
Nastiti, K., Benton, D., Brain, P. F., & Haug, M. (1991) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80136-8 · Cited by 24
Propofol produces anticonflict action by inhibiting 5-HT release in rat dorsal hippocampus
Matsuo, M., Ayuse, T., Oi, K., & Kataoka, Y. (1997) · Neuroreport · doi:10.1097/00001756-199709290-00016 · Cited by 24
The Three Rs and Biomedical Research
Goldberg, A. M., Zurlo, J., & Rudacille, D. (1996) · Science · doi:10.1126/science.272.5267.1403 · Cited by 24
Susceptibility of a potential animal model for pathological anxiety to chronic mild stress
Salomons, A. R., Kortleve, T., Reinders, N. R., Kirchhoff, S., Arndt, S. S., & Ohl, F. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.01.050 · Cited by 24
Models of Anxiety: Ultrasonic Vocalizations of Isolated Rat Pups
Groenink, L., Verdouw, P. M., van Oorschot, R., & Olivier, B. (2008) · Current Protocols in Pharmacology · doi:10.1002/0471141755.ph0518s43 · Cited by 23
Eisener-Dorman, A. F., Lawrence, D. A., & Bolivar, V. J. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.05.002 · Cited by 23
The Mousetrap: Managing the Placebo Effect in Antidepressant Trials
Lakoff, A. (2002) · Molecular Interventions · doi:10.1124/mi.2.2.72 · Cited by 23
Heldt, S. A., Davis, M., Ratti, E., Corsi, M., Trist, D. G., & Ressler, K. J. (2009) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32832ec594 · Cited by 23
Yeragani, V. K., Pohl, R. B., Balon, R., Rainey, J. M., Berchou, R. C., & Ortiz, A. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90252-1 · Cited by 21
Shekhar, A., Johnson, P. L., Fitz, S. D., Nakazato, A., Chaki, S., Steckler, T., & Schmidt, M. E. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710001355 · Cited by 21
Sluyter, F., Korte, S. M., van Baal, G. C. M., de Ruiter, A. J. H., & van Oortmerssen, G. A. (1999) · Physiology & Behavior · doi:10.1016/s0031-9384(99)00101-8 · Cited by 21
Developing Novel Anxiolytics: Improving Preclinical Detection and Clinical Assessment
Steckler, T., Stein, M. B., & Holmes, A. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373861-5.00005-9 · Cited by 20
Use of conditioned taste aversion as a conflict model: effects of anxiolytic drugs.
Ervin, G. N., & Cooper, B. R. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22297-2 · Cited by 19
Elevated anxiety-like and depressive behavior in Desert hedgehog knockout male mice
Umehara, F., Mishima, K., Egashira, N., Ogata, A., Iwasaki, K., & Fujiwara, M. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.07.022 · Cited by 17
Benvenga, M. J., Overshiner, C. D., Monn, J. A., & Leander, J. D. (1999) · Drug Development Research · doi:10.1002/(sici)1098-2299(199905)47:1<37::aid-ddr5>3.0.co;2-s · Cited by 17
Yeragani, V. K., Pohl, R. B., Bär, K., Chokka, P. R., & Tancer, M. E. (2007) · Neuropsychobiology · doi:10.1159/000108380 · Cited by 17
Young, E. A., Garfinkel, S. N., & Liberzon, I. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00091-7 · Cited by 16
Paterson, N. E., & Hanania, T. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.12.006 · Cited by 16
Therapeutic area influences drug development costs
Frantz, S. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1436 · Cited by 16
Associations between personality traits and CCK-4-induced panic attacks in healthy volunteers
Tõru, I., Aluoja, A., Võhma, Ü., Raag, M., Vasar, V., Maron, E., & Shlik, J. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2010.04.003 · Cited by 16
Vinkers, C. H., Cryan, J. F., Olivier, B., & Groenink, L. (2010) · The Open Pharmacology Journal · doi:10.2174/1874143601004010001 · Cited by 14
Self-citationSeed Finding in Golden Hamsters: A Potential Animal Model for Screening Anxiolytic Drugs
King, J. A., Messenger, T. L., & Ferris, C. F. (2002) · Neuropsychobiology · doi:10.1159/000054956 · Cited by 13
Peripheral gene expression profiling of CCK‐4‐induced panic in healthy subjects
Maron, E., Kallassalu, K., Tammiste, A., Kolde, R., Vilo, J., Tõru, I., Vasar, V., Shlik, J., & Metspalu, A. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30898 · Cited by 13
Modeling Human Anxiety and Depression in Mutant Mice
Holmes, A., & Cryan, J. F. (2006) · Contemporary clinical neuroscience · doi:10.1007/978-1-59745-058-4_12 · Cited by 12
Self-citationAbnormalities in aggression and anxiety in transgenic mice overexpressing activin E
Sekiyama, K., Hashimoto, O., Ushiro, Y., Adachi, C., Kikusui, T., Tanemura, K., & Hasegawa, Y. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.05.054 · Cited by 12
Commissaris, R. L., Ardayfio, P. A., McQueen, D. A., Gilchrist, G. A., & Overstreet, D. H. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00314-2 · Cited by 11
Pharmacological modulation of anxiety-related behaviors in the murine Suok test
Kalueff, A. V., Keisala, T., Minasyan, A., & Tuohimaa, P. (2007) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2007.05.002 · Cited by 11
The Internal Conflict Model: A Theoretical Framework for Integration.
Sato, T. (2005) · The Humanistic Psychologist · doi:10.1207/s15473333thp3301_4 · Cited by 10
Zwanzger, P., Eser, D., Romeo, E., di Michele, F., Baghai, T. C., Pasini, A., Padberg, F., & Rupprecht, R. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.04.017 · Cited by 9
Young, E. A., & Liberzon, I. (2002) · Elsevier eBooks · doi:10.1016/b978-012532104-4/50098-6 · Cited by 8
Does the melanin-concentrating hormone antagonist SNAP-7941 deserve 3As?
Doggrell, S. A. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.6.1035 · Cited by 6
Maron, E., Tõru, I., Mäemets, K., Sepp, S., Vasar, V., Shlik, J., & Zharkovsky, A. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108089600 · Cited by 6
Implications of Genomics for Public Health: The Role of Genetic EpidemiologyPreprint
Merikangas, K. R. (2003) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2003.68.359 · Cited by 5
Zwanzger, P., Jarry, H., Eser, D., Padberg, F., Baghai, T. C., Schüle, C., Ella, R., M�ller, H.-J., & Rupprecht, R. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-002-0774-8 · Cited by 4
Cited by
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
Cryan, J. F., & Dinan, T. G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3346 · Cited by 4,572
Self-citationClarke, G., Grenham, S., Scully, P., Fitzgerald, P., Moloney, R. D., Shanahan, F., Dinan, T. G., & Cryan, J. F. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.77 · Cited by 1,893
Self-citationAnimal models of anxiety disorders and stress
Campos, A. C., Fogaca, M. V., Aguiar, D. C., & Guimaraes, F. S. (2013) · Revista Brasileira de Psiquiatria · doi:10.1590/1516-4446-2013-1139 · Cited by 471
Belzung, C., & Lemoine, M. (2011) · Biology of Mood & Anxiety Disorders · doi:10.1186/2045-5380-1-9 · Cited by 438
Savignac, H. M., Kiely, B., Dinan, T. G., & Cryan, J. F. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12427 · Cited by 418
Metadata
- Authors
- Cryan, J. F., & Sweeney, F. F.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2011-10
- Volume
- 164
- Issue
- 4
- Pages
- 1129-1161
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1545745337
- Cited by
- 316
- References
- 361
- FWCI
- 7.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.